Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19
Shigeru Shibata, Hisatomi Arima, Kei Asayama, et al.
Hypertension Research (2020) Vol. 43, Iss. 10, pp. 1028-1046
Open Access | Times Cited: 170

Showing 1-25 of 170 citing articles:

Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension
Bin Zhou, Pablo Perel, George A. Mensah, et al.
Nature Reviews Cardiology (2021) Vol. 18, Iss. 11, pp. 785-802
Open Access | Times Cited: 937
SARS-CoV-2 and Oral Manifestation: An Observational, Human Study
Bruna Sinjari, Damiano D’Ardes, Manlio Santilli, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 10, pp. 3218-3218
Open Access | Times Cited: 87
Metabolic Implications of Oxidative Stress and Inflammatory Process in SARS-CoV-2 Pathogenesis: Therapeutic Potential of Natural Antioxidants
Gilead Ebiegberi Forcados, Aliyu Muhammad, Olusola O. Oladipo, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 84
Long-term clinical and biochemical residue after COVID-19 recovery
Mohammed Ali Gameil, Rehab Elsayed Marzouk, Ahmed EL-Sebaie, et al.
Egyptian Liver Journal (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 68
Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19
Chisa Matsumoto, Shigeru Shibata, Takuya Kishi, et al.
Hypertension Research (2022) Vol. 46, Iss. 3, pp. 601-619
Open Access | Times Cited: 41
Seven‐action approaches for the management of hypertension in Asia – The HOPE Asia network
Kazuomi Kario, Yook Chin Chia, Saulat Siddique, et al.
Journal of Clinical Hypertension (2022) Vol. 24, Iss. 3, pp. 213-223
Open Access | Times Cited: 39
Efficacy and safety of tixagevimab‐cilgavimab as pre‐exposure prophylaxis for COVID‐19: A systematic review and meta‐analysis
Arto Yuwono Soeroto, Theo Audi Yanto, Andree Kurniawan, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 2
Closed Access | Times Cited: 33
ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19
Kōichi Yamamoto, Hikari Takeshita, Hiromi Rakugi
Clinical Science (2020) Vol. 134, Iss. 22, pp. 3047-3062
Open Access | Times Cited: 53
A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19
Emmanuelle Logette, Charlotte Lorin, Cyrille Favreau, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 51
Renin–angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study
Yasushi Matsuzawa, Hisao Ogawa, Kazuo Kimura, et al.
Hypertension Research (2020) Vol. 43, Iss. 11, pp. 1257-1266
Open Access | Times Cited: 49
The impact of pre-existing hypertension and its treatment on outcomes in patients admitted to hospital with COVID-19
Ewan McFarlane, Marijke Linschoten, Folkert W. Asselbergs, et al.
Hypertension Research (2022) Vol. 45, Iss. 5, pp. 834-845
Open Access | Times Cited: 29
Impact of cytokine storm on severity of COVID-19 disease in a private hospital in West Jakarta prior to vaccination
Diana Laila Ramatillah, Siew Hua Gan, Ika Pratiwy, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0262438-e0262438
Open Access | Times Cited: 27
Hypertension management before and under the COVID-19 pandemic: lessons and future directions
Yoichi Nozato, Kōichi Yamamoto, Hiromi Rakugi
Hypertension Research (2023) Vol. 46, Iss. 6, pp. 1471-1477
Open Access | Times Cited: 17
The trends of antihypertensive drug prescription based on the Japanese national data throughout the COVID-19 pandemic period
Shotaro Natsume, Michihiro Satoh, Takahisa Murakami, et al.
Hypertension Research (2024)
Open Access | Times Cited: 5
Clinical risk factors for mortality in patients with cancer and COVID-19: a systematic review and meta-analysis of recent observational studies
Liu Yang, Huan Lu, Wei Wang, et al.
Expert Review of Anticancer Therapy (2020) Vol. 21, Iss. 1, pp. 107-119
Closed Access | Times Cited: 40
Hypertension as an independent risk factor for severity and mortality in patients with COVID-19: a retrospective study
Jiankun Chen, Yuntao Liu, Jinying Qin, et al.
Postgraduate Medical Journal (2021) Vol. 98, Iss. 1161, pp. 515-522
Open Access | Times Cited: 37
Implications of testicular ACE2 and the renin–angiotensin system for SARS-CoV-2 on testis function
R. Clayton Edenfield, Charles A. Easley
Nature Reviews Urology (2021) Vol. 19, Iss. 2, pp. 116-127
Open Access | Times Cited: 37
Susceptibility to Coronavirus (COVID-19) in Occupational Settings: The Complex Interplay between Individual and Workplace Factors
Veruscka Leso, Luca Fontana, Ivo Iavicoli
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 3, pp. 1030-1030
Open Access | Times Cited: 36
COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19
Shigeru Shibata, Kazuo Kobayashi, Masami Tanaka, et al.
Hypertension Research (2022) Vol. 46, Iss. 3, pp. 589-600
Open Access | Times Cited: 24
Prevalence of hypertension and associated risks in hospitalized patients with COVID-19: a meta-analysis of meta-analyses with 1468 studies and 1,281,510 patients
Yousof Khairy, Deniz Naghibi, Ahmad Moosavi, et al.
Systematic Reviews (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 23
Health system adaptions to improve care for people living with non-communicable diseases during COVID-19 in low-middle income countries: A scoping review
Leonard Baatiema, Olutobi Adekunle Sanuade, Luke Allen, et al.
Journal of Global Health (2023) Vol. 13
Open Access | Times Cited: 13
Peak home blood pressure as an earlier and strong novel risk factor for stroke: the practitioner-based nationwide J-HOP study extended
Kazuomi Kario, Naoko Tomitani, Takeshi Fujiwara, et al.
Hypertension Research (2023) Vol. 46, Iss. 9, pp. 2113-2123
Open Access | Times Cited: 12
Digital therapeutics for essential hypertension using a smartphone application: A randomized, open‐label, multicenter pilot study
Kazuomi Kario, Akihiro Nomura, Ayaka Kato, et al.
Journal of Clinical Hypertension (2021) Vol. 23, Iss. 5, pp. 923-934
Open Access | Times Cited: 30
Role of Hydrogen Bonds in Formation of Co-amorphous Valsartan/Nicotinamide Compositions of High Solubility and Durability with Anti-hypertension and Anti-COVID-19 Potential
Marika Turek, Ewa Różycka‐Sokołowska, Marek Koprowski, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 5, pp. 1970-1984
Open Access | Times Cited: 30
The first software as medical device of evidence-based hypertension digital therapeutics for clinical practice
Kazuomi Kario, Noriko Harada, Ayako Okura
Hypertension Research (2022) Vol. 45, Iss. 12, pp. 1899-1905
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top